IBDEI0KO ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9792,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,9792,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,9793,0)
 ;;=374.53^^44^557^36
 ;;^UTILITY(U,$J,358.3,9793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9793,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,9793,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,9793,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,9794,0)
 ;;=374.54^^44^557^35
 ;;^UTILITY(U,$J,358.3,9794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9794,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,9794,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,9794,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,9795,0)
 ;;=374.56^^44^557^39
 ;;^UTILITY(U,$J,358.3,9795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9795,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,9795,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,9795,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,9796,0)
 ;;=374.81^^44^557^33
 ;;^UTILITY(U,$J,358.3,9796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9796,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,9796,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,9796,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,9797,0)
 ;;=374.82^^44^557^32
 ;;^UTILITY(U,$J,358.3,9797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9797,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,9797,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,9797,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,9798,0)
 ;;=374.85^^44^557^45
 ;;^UTILITY(U,$J,358.3,9798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9798,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,9798,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,9798,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,9799,0)
 ;;=374.86^^44^557^38
 ;;^UTILITY(U,$J,358.3,9799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9799,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,9799,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,9799,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,9800,0)
 ;;=376.11^^44^557^89
 ;;^UTILITY(U,$J,358.3,9800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9800,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
 ;;^UTILITY(U,$J,358.3,9800,1,4,0)
 ;;=4^376.11
 ;;^UTILITY(U,$J,358.3,9800,2)
 ;;=^269176
 ;;^UTILITY(U,$J,358.3,9801,0)
 ;;=376.21^^44^557^93
 ;;^UTILITY(U,$J,358.3,9801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9801,1,3,0)
 ;;=3^Orbit Thyrotoxic Exophthalmos
 ;;^UTILITY(U,$J,358.3,9801,1,4,0)
 ;;=4^376.21
 ;;^UTILITY(U,$J,358.3,9801,2)
 ;;=^269181
 ;;^UTILITY(U,$J,358.3,9802,0)
 ;;=376.33^^44^557^83
 ;;^UTILITY(U,$J,358.3,9802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9802,1,3,0)
 ;;=3^Orbit Edema
 ;;^UTILITY(U,$J,358.3,9802,1,4,0)
 ;;=4^376.33
 ;;^UTILITY(U,$J,358.3,9802,2)
 ;;=^269186
 ;;^UTILITY(U,$J,358.3,9803,0)
 ;;=376.40^^44^557^82
 ;;^UTILITY(U,$J,358.3,9803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9803,1,3,0)
 ;;=3^Orbit Deformity,Unspec
 ;;^UTILITY(U,$J,358.3,9803,1,4,0)
 ;;=4^376.40
 ;;^UTILITY(U,$J,358.3,9803,2)
 ;;=^269191
 ;;^UTILITY(U,$J,358.3,9804,0)
 ;;=376.41^^44^557^90
 ;;^UTILITY(U,$J,358.3,9804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9804,1,3,0)
 ;;=3^Orbit Hypertelorism
 ;;^UTILITY(U,$J,358.3,9804,1,4,0)
 ;;=4^376.41
 ;;^UTILITY(U,$J,358.3,9804,2)
 ;;=^269192
 ;;^UTILITY(U,$J,358.3,9805,0)
 ;;=376.43^^44^557^81
 ;;^UTILITY(U,$J,358.3,9805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9805,1,3,0)
 ;;=3^Orbit Deformity d/t Bone Disease
 ;;^UTILITY(U,$J,358.3,9805,1,4,0)
 ;;=4^376.43
 ;;^UTILITY(U,$J,358.3,9805,2)
 ;;=^269196
 ;;^UTILITY(U,$J,358.3,9806,0)
 ;;=376.44^^44^557^80
 ;;^UTILITY(U,$J,358.3,9806,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0KO
